KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
Jun 23, 2022 $0.268 $0.286 $0.268 $0.281 640 999
Jun 22, 2022 $0.260 $0.291 $0.253 $0.265 550 777
Jun 21, 2022 $0.250 $0.280 $0.250 $0.269 1 194 607
Jun 17, 2022 $0.243 $0.279 $0.243 $0.270 521 280
Jun 16, 2022 $0.250 $0.270 $0.240 $0.250 654 964
Jun 15, 2022 $0.253 $0.273 $0.253 $0.254 413 004
Jun 14, 2022 $0.255 $0.274 $0.245 $0.261 982 971
Jun 13, 2022 $0.273 $0.273 $0.245 $0.254 668 291
Jun 10, 2022 $0.285 $0.289 $0.271 $0.273 974 597
Jun 09, 2022 $0.262 $0.305 $0.254 $0.287 1 770 937
Jun 08, 2022 $0.280 $0.289 $0.261 $0.269 756 282
Jun 07, 2022 $0.255 $0.290 $0.245 $0.272 1 439 405
Jun 06, 2022 $0.260 $0.265 $0.250 $0.253 241 823
Jun 03, 2022 $0.250 $0.265 $0.245 $0.248 442 071
Jun 02, 2022 $0.252 $0.261 $0.250 $0.252 221 102
Jun 01, 2022 $0.250 $0.265 $0.242 $0.258 1 319 541
May 31, 2022 $0.270 $0.270 $0.250 $0.250 341 058
May 27, 2022 $0.260 $0.260 $0.247 $0.260 209 013
May 26, 2022 $0.233 $0.260 $0.227 $0.242 1 133 657
May 25, 2022 $0.252 $0.255 $0.230 $0.233 442 059
May 24, 2022 $0.265 $0.266 $0.242 $0.242 429 156
May 23, 2022 $0.270 $0.279 $0.261 $0.266 186 776
May 20, 2022 $0.269 $0.280 $0.269 $0.274 247 092
May 19, 2022 $0.270 $0.277 $0.251 $0.272 315 687
May 18, 2022 $0.250 $0.270 $0.250 $0.265 421 350
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT